The Week in Review in Drug Pricing

What’s hotter in D.C. right now — drug prices or the heat index?

1. Trust No One

2. Oh, Canada 🇨🇦

  • We want patients to buy prescriptions at reasonable prices, but we can’t rely on our northern neighbor forever. — (Reuters)


3. All a blur

  • Tracking drug pricing proposals makes our heads spin on the weekly. Here’s a handy guide. — (STAT)


4. “My love for you is like drug list prices: inexplicable.”

  • Totally inexplicable — (NPR)


5. Weekend read

  • AbbVie’s abusive tactics to maintain its monopoly on its $20 billion blockbuster, Humira, thoroughly dissected. — (Fortune)